The iBOT is a Surgical / Medical robot developed by DEKA, launched 2022, listed at $25,000–$30,000 USD (unverified). Key specifications: fda year Class II (reclassified in 2014)[4], ce mark year true, pricing model purchase.
RoboScore
Adequate evidence
No confirmed deployment on record — this score reflects the rest of the record, not verified adoption.
5 of 9 signals present
Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.
Weighted factors
average of the 5 scored · blanks don't count
Ranked #29 of 59 in the Surgical / Medical standing.
See the standingWhere it has stood41 days · best #23 · worst #29
Nothing changed about this robot itself — what you can see is the field shifting around it, or its maker's news rising and ageing.
One reading per day since 3 Aug, when the current ordering began. The rank above is the reading for 12 Sept, taken against 59 robots — the standing itself is live, so a robot added since then counts there and not here yet.
Will it fit your job?
Tell us the job in plain words — we'll show how this robot measures up, line by line.
Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how iBOT measures up, requirement by requirement. The RoboScore (trust) above is shown for every buyer, regardless.
Overview
The iBOT is a robotic wheelchair invented by Dean Kamen. It can navigate rough terrain and climb stairs, showcasing advanced mobility solutions for individuals with disabilities.
Flagship features
- Notable user stories: Mobius Mobility highlights 'user stories' on their site, suggesting real-world deployments
- Compatible with EZ Lock docking system for vehicle transport
- Remote Mode allows unoccupied operation for loading into vehicles (up to 20-degree incline)
- Terrain-following technology automatically adjusts seat angle on slopes
- Sealed electronics, batteries, and motors — can be hosed down after outdoor use
- Market context: The ibot brand was originally developed by DEKA and later acquired by Mobius Mobility
Buyer decision signals
Viability
Company founded
Availability
Specifications
Category: Surgical / Medical- FDA year
- Class II (reclassified in 2014)[4]
- CE mark year
- true
- Pricing model
- purchase
Company profile
- Founded
- 1982
Detailed specifications
What it is built for1
- Sub Category
- personal mobility
Movement & precision1
- Max Speed M S
- 3.03
Controls & integration1
- Controller Model
- Redundant 32-bit embedded microcontrollers[2]
Buying & support1
- Availability Status
- available
Who runs it· deployment evidence
No deployment evidence on file
A deployment is recorded when a public source names the customer, or the maker confirms it. Nothing here counts against this robot.
10 other robots in this category have one.
Add a deployment →Where to buy
Get a price or reach an authorized seller — pick your region, then request a quote.
No authorized seller is listed for this robot yet — request a quote below and we’ll connect you with DEKA or an authorized seller.
Request a quote — goes straight to DEKA.
Every authorized seller serving your region is shown equally — placement is never sold, and this data never affects a robot’s score. A seller’s absence here doesn’t mean they aren’t authorized.
Company milestones
- 1982MilestoneCompany founded
- —MilestoneManchester headquarters
- —LaunchRobotic prostheses and advanced technologies
Frequently asked questions
- Who makes the iBOT?
- The iBOT is developed by DEKA.
- What type of robot is the iBOT?
- The iBOT is a Surgical / Medical robot made by DEKA.
- How much does the iBOT cost?
- The iBOT is listed at $25,000–$30,000 USD in the Robolist catalogue, but this figure is unverified and not confirmed by DEKA — contact them for a quote.
- When was the iBOT launched?
- The iBOT was launched in 2022.
- What are the key specifications of the iBOT?
- Key specifications of the iBOT: fda year Class II (reclassified in 2014)[4], ce mark year true, pricing model purchase.
Reviews for iBOT
Loading reviews…
